100
Participants
Start Date
October 1, 2019
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2027
Carboplatin
Chemotherapy FDA approved drug used to treat: ovarian, lung, head and neck cancers. It is sometimes used in combination with other medications or off-label use to treat other metastatic cancers.
Olaparib
Olaparib is a targeted therapy drug that is used for mCRPC and is approved by the FDA for this use.
RECRUITING
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
RECRUITING
Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
RECRUITING
Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
RECRUITING
Orlando VA Medical Center, Orlando, FL, Orlando
RECRUITING
VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
TERMINATED
Jesse Brown VA Medical Center, Chicago, IL, Chicago
RECRUITING
Kansas City VA Medical Center, Kansas City, MO, Kansas City
RECRUITING
Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
RECRUITING
Boise VA Medical Center, Boise, ID, Boise
RECRUITING
VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
RECRUITING
VA Portland Health Care System, Portland, OR, Portland
RECRUITING
Washington DC VA Medical Center, Washington, DC, Washington D.C.
TERMINATED
Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines
RECRUITING
Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
TERMINATED
James J. Peters VA Medical Center, Bronx, NY, The Bronx
RECRUITING
Durham VA Medical Center, Durham, NC, Durham
RECRUITING
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
RECRUITING
William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
VA Office of Research and Development
FED